ARKK vs ORMP
ARK Innovation ETF (ARKK) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
ARKK does not have a complete income-statement cache yet.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
ARKK currently screens at market cap $0. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the ARKK and ORMP stock pages for the full models.
Not investment advice.